U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Abnormal rapid eye movement sleep

MedGen UID:
488885
Concept ID:
C0392188
Finding
Synonym: Abnormal rapid eye movement (REM) sleep
SNOMED CT: Abnormal rapid eye movement sleep (69020003); Abnormal REM sleep (69020003)
 
HPO: HP:0002494

Definition

Abnormality of REM Sleep are phases of REM sleep are characterized by desynchronized EEG patterns, increases in heart rate and blood pressure, sympathetic activation, and a profound loss of muscle tone except for the eye and middle-ear muscles. There are also phases of rapid eye movements. [from HPO]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVAbnormal rapid eye movement sleep

Conditions with this feature

Narcolepsy 1
MedGen UID:
371809
Concept ID:
C1834372
Disease or Syndrome
Adie (1926) first delineated narcolepsy as a separate and specific entity. It is a sleep disorder characterized by attacks of disabling daytime drowsiness and low alertness. The normal physiologic components of rapid eye movement (REM) sleep, dreaming and loss of muscle tone, are separated and also occur while the subject is awake, resulting in half-sleep dreams and episodes of skeletal muscle paralysis and atonia (cataplexy and sleep paralysis). Unlike normal sleep, that of narcolepsy often begins with REM activity and the time taken to fall asleep is shorter than normal. In contrast to animal models, human narcolepsy is not a simple genetic disorder. Most human cases of narcolepsy are sporadic and carry a specific HLA haplotype (Peyron et al., 2000). Familial cases are the exception rather than the rule, and monozygotic twins show only partial concordance (25 to 31%) (Mignot, 1998). Genetic Heterogeneity of Narcolepsy Additional narcolepsy loci have been mapped to chromosomes 4 (NRCLP2; 605841), 21q (NRCLP3; 609039), 22q13 (NRCLP4; 612417), 14q11 (NRCLP5; 612851), and 19p13.2 (NRCLP6; 614223). NRCLP7 (614250) is caused by mutation in the MOG gene (159465) on chromosome 6p22. Resistance to narcolepsy is associated with minor alleles of a SNP and a marker in the NLC1A gene (610259) on chromosome 21q22.
Narcolepsy 3
MedGen UID:
332320
Concept ID:
C1836907
Disease or Syndrome
Narcolepsy is a chronic sleep disorder that disrupts the normal sleep-wake cycle. Although this condition can appear at any age, it most often begins in adolescence.\n\nNarcolepsy is characterized by excessive daytime sleepiness. Affected individuals feel tired during the day, and several times a day they may experience an overwhelming urge to sleep. "Sleep attacks" can occur at unusual times, such as during a meal or in the middle of a conversation. They last from a few seconds to a few minutes and often lead to a longer nap, after which affected individuals wake up feeling refreshed.\n\nAnother common feature of narcolepsy is cataplexy, which is a sudden loss of muscle tone in response to strong emotion (such as laughing, surprise, or anger). These episodes of muscle weakness can cause an affected person to slump over or fall, which occasionally leads to injury. Episodes of cataplexy usually last just a few seconds, and they may occur from several times a day to a few times a year. Most people diagnosed with narcolepsy also have cataplexy. However, some do not, which has led researchers to distinguish two major forms of the condition: narcolepsy with cataplexy and narcolepsy without cataplexy.\n\nNarcolepsy also affects nighttime sleep. Most affected individuals have trouble sleeping for more than a few hours at night. They often experience vivid hallucinations while falling asleep (hypnogogic hallucinations) or while waking up (hypnopompic hallucinations). Affected individuals often have realistic and distressing dreams, and they may act out their dreams by moving excessively or talking in their sleep. Many people with narcolepsy also experience sleep paralysis, which is an inability to move or speak for a short period while falling asleep or awakening. The combination of hallucinations, vivid dreams, and sleep paralysis is often frightening and unpleasant for affected individuals.\n\nSome people with narcolepsy have all of the major features of the disorder, while others have only one or two. Most of the signs and symptoms persist throughout life, although episodes of cataplexy may become less frequent with age and treatment.
Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome
MedGen UID:
482853
Concept ID:
C3281223
Disease or Syndrome
Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome (CANVAS) is an autosomal recessive adult-onset, slowly progressive neurologic disorder characterized by imbalance due to cerebellar gait and limb ataxia, impaired vestibular function bilaterally, and non-length-dependent sensory neuropathy (summary by Szmulewicz et al., 2011).
Autosomal dominant cerebellar ataxia, deafness and narcolepsy
MedGen UID:
813625
Concept ID:
C3807295
Disease or Syndrome
ADCADN is an autosomal dominant neurologic disorder characterized by adult onset of progressive cerebellar ataxia, narcolepsy/cataplexy, sensorineural deafness, and dementia. More variable features include optic atrophy, sensory neuropathy, psychosis, and depression (summary by Winkelmann et al., 2012).

Professional guidelines

PubMed

Prange S, Klinger H, Laurencin C, Danaila T, Thobois S
Drugs Aging 2022 Jun;39(6):417-439. Epub 2022 Jun 16 doi: 10.1007/s40266-022-00942-1. PMID: 35705848Free PMC Article
Levin J, Kurz A, Arzberger T, Giese A, Höglinger GU
Dtsch Arztebl Int 2016 Feb 5;113(5):61-9. doi: 10.3238/arztebl.2016.0061. PMID: 26900156Free PMC Article
Wichniak A, Wierzbicka A, Jernajczyk W
Curr Pharm Des 2012;18(36):5802-17. doi: 10.2174/138161212803523608. PMID: 22681161

Recent clinical studies

Etiology

Feemster JC, Steele TA, Palermo KP, Ralston CL, Tao Y, Bauer DA, Edgar L, Rivera S, Walters-Smith M, Gossard TR, Teigen LN, Timm PC, Richardson JW, Auger RR, Kolla B, McCarter SJ, Boeve BF, Silber MH, St Louis EK
Sleep 2022 Mar 14;45(3) doi: 10.1093/sleep/zsab259. PMID: 34958372Free PMC Article
Chen YH, Huang YS, Chien WH, Chen CH
Sleep Med 2013 Dec;14(12):1393-7. Epub 2013 Sep 29 doi: 10.1016/j.sleep.2013.06.017. PMID: 24157097
Mignot E
Curr Opin Pulm Med 1996 Nov;2(6):482-7. PMID: 9363189
Scharf MB, Hemsath R, Lysaght RJ, De Marchis M, Zipkin J
J Urol 1983 Nov;130(5):909-11. doi: 10.1016/s0022-5347(17)51571-2. PMID: 6632097

Diagnosis

Liguori R, Vincent A, Clover L, Avoni P, Plazzi G, Cortelli P, Baruzzi A, Carey T, Gambetti P, Lugaresi E, Montagna P
Brain 2001 Dec;124(Pt 12):2417-26. doi: 10.1093/brain/124.12.2417. PMID: 11701596
Mignot E
Curr Opin Pulm Med 1996 Nov;2(6):482-7. PMID: 9363189

Therapy

Mignot E
Curr Opin Pulm Med 1996 Nov;2(6):482-7. PMID: 9363189

Prognosis

Liguori R, Vincent A, Clover L, Avoni P, Plazzi G, Cortelli P, Baruzzi A, Carey T, Gambetti P, Lugaresi E, Montagna P
Brain 2001 Dec;124(Pt 12):2417-26. doi: 10.1093/brain/124.12.2417. PMID: 11701596

Clinical prediction guides

Nishida N, Murakami T, Kadoh K, Tohge R, Yamanegi M, Saiki H, Ueda K, Matsumoto S, Ishikawa M, Takahashi JA, Toda H
Mov Disord 2011 Nov;26(13):2418-22. Epub 2011 Jul 7 doi: 10.1002/mds.23862. PMID: 22109851

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...